RRM1 and urinary bladder carcinoma: On the other hand, Bellmun et al. [16] failed to demonstrate the predictive value of RRM1 mRNA levels for survival outcome as well as chemotherapy response in advanced bladder cancer in patients receiving cisplatin-based chemotherapy, but not limited to combination with gemcitabine.